Jesus Donas-Garcia - Publications

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 04, 2025

Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 12, 2025

External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy.

Journal: European journal of endocrinology

Published: December 30, 2024

Does Adjuvant Mitotane Impact Cure Rates in Adrenocortical Carcinoma? Insights From the ICARO-GETTHI/SEEN Registry.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 12, 2024

Autoencoder techniques for survival analysis on renal cell carcinoma.

Journal: PloS one

Published: October 16, 2024

Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 08, 2024

Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016-01).

Journal: Gynecologic oncology

Published: September 18, 2024

Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 18, 2024

Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.

Journal: Future oncology (London, England)

Published: August 12, 2024

Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 24, 2024

CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds.

Journal: Molecular oncology

Published: July 10, 2024

Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 14, 2024